glp-1 mimetics Glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide analogues in adults with type 2 diabetes mellitus for glycaemic control Glucagon-like peptide-1 receptor: mechanisms and

This is the second time Pfizer has pulled back on danuglipron, with the company previously discontinuing a twice-daily version in late 2023 due to tolerability concerns

Different Delivery Format: Vials require drawing up doses rather than using pre-filled pens (though many prefer this)

Bradley, MD Jul 10, 2024 3 min read Around 20 years ago, I led a research trial using the antidepressant Wellbutrin to try and cause weight loss in healthy volunteers

We explain costs up front and monitor progress every step of the way

Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab)